Security Research
ISBP
A Phase-2-origin security threat discovery under ZOE. A mitigation architecture exists but its sensitive mechanics are retained for controlled / NDA review.
Canonical nowZOE-linked
Open ISBP →Why this route exists
Do not force research into a product-shaped box.
Some Phase 2 work is best reviewed through research questions: Is the problem real? Is the architecture coherent? Is the finding reproducible? Is the idea novel? What has been implemented or tested? What remains confidential? Each asset answers those questions differently.
Classification rule
Research placement does not imply weakness, incompleteness or lack of implementation. It means the primary review lens is research, theory, protocol or threat discovery rather than current product operation.
Current research map
Three high-signal research families.
Protocol Research
HDTP
A Phase-2-origin protocol-research architecture for constrained communication. The architecture is documented; the technical core is reserved and its strongest performance claims require controlled, independent review.
Canonical nowIP-sensitive
Open HDTP →Foundational Research
BioCode
A Phase-2-origin foundational research architecture for biological intelligence, limitation, embodiment, consequence, salience, memory, emotion-as-signal, self-correction, and human-grounded AI.
Canonical now
Open BioCode →Reading model
Four questions before any verdict.
01
Provenance
When and under what human-contributor boundary was the research formed?
02
Substance
What documents, architecture, implementation, tests or research artifacts actually exist?
03
Disclosure
Which parts can be public, and which are restricted because of IP, security or misuse risk?
04
Validation
Which claims can be independently reproduced, challenged or verified in Phase 3?